References
- Lawson DH, Paice BJ. Adverse reactions to trimethoprim-sulfamethoxazole. Rev Infect Dis 1982: 4(2): 429–33
- Trimethoprim. Med Lett Drugs Ther 1980: 22(17): 69–70
- Chanarin I, England JM. Toxicity of trimethoprim-sulphamethoxazole in patients with megaloblastic haemopoiesis. BMJ 1972: 1 (801): 651–3
- Jenkins GC, Hughes DT, Hall PC. A haematological study of patients receiving long-term treatment with trimethoprim and sulphonamide. J Clin Pathol 1970: 23(5): 392–6
- Kobrinsky NL, Ramsay NK. Acute megaloblastic anemia induced by high-dose trimethoprim-sulfamethoxazole. Ann Intern Med 1981: 94(6): 780–1
- Dawson DW, Rutledge RC. Trimethoprim and sulfamethoxazole. (Letter) BMJ 1971: 2(Nov 6): 364
- Asmar BI, Maqbool S, Dajani AS. Hematologic abnormalities after oral trimethoprim-sulfamethoxazole therapy in children. Am J Dls Child 1981: 135(12): 1100–3
- Wormser GP, Keusch GT. Trimethoprim-sulfamethoxazole in the United States. Ann Intern Med 1979: 91(3): 420–9
- Koch-Weser J, Sidel VW, Dexter M, et al. Adverse reactions to sulfosoxazole, sulfamethoxazole, and nitrofurantoin: manifestations and specific reaction rates during 2,118 courses of therapy. Arch Intern Med 1971: 128(3): 399–404
- Pirofsky B. When autoimmune hemolytic anemia complicates chronic lymphocytic leukemia. Geriatrics 1978: 33(4): 71–9